Switzerland - Effective Date of Furocoumarin Restriction ✅1 January 2026: In finished cosmetic products, excluding perfumes, eaux de toilette and eau de cologne, the sum of the concentrations of the furocoumarins Byakangelicol, Epoxy-bergamottin, Isopimpinellin, 5-Methoxypsoralen, 8-Methoxypsoralen, Oxypeucedanin, Oxypeucedanin hydrate and Psoralen must be present in quantities below 1 mg/kg, and natural essential oils must be dosed accordingly, where, under…

France - PFAS prohibition effective date ✅01 January 2026: New prohibition for making available on the market products containing intentionally added PFAS The 01 January 2026 PFAS ban is approaching, and timely compliance is key to keeping your products on the market without interruption. Obelis is here to provide expert guidance and practical support, ensuring you meet the…

United Kingdom - Benzophenone‑3 & Methyl Salicylate Restrictions Deadlines ✅21 January 2026: Cosmetic products containing Benzophenone-3 and not complying with the restrictions outlined in Annex VI can no longer be placed on Great Britain’s market. For full details on the restrictions, please refer to this link. ✅31 March 2026: Cosmetic products containing Methyl Salicylate (CAS 119-36-8)and not complying with the…

Canada - Fragrance Allergen Disclosure Deadline ✅12 April 2026: New and existing cosmetics have to disclose the 24 fragrance allergens listed below within the list of ingredients, when present at concentration greater than 0.01% in rinse-off products and 0.001% in leave-on products. To ensure compliance with the above regulatory changes, we recommend reviewing and, where…

European Union - Omnibus Act VIII amends the Cosmetic Regulations ✅1 May 2026: Products containing 3-(4′-methylbenzylidene)-camphor  (CAS No 36861-47-9/38102-62-4) can no longer be made available on the market. ✅1 May 2026: With no distinction between placing products on the market and making them available, Omnibus Act VIII will apply. This means that, from the application date, non-compliant cosmetics can…

As the transition to the In Vitro Diagnostic Regulation (IVDR) continues, we would like to remind you of the critical 2026 deadlines for legacy IVDs that are classified to Class C under IVDR. For these devices, the following milestones apply:  ✅A written agreement between the manufacturer and the Notified Body must be signed by 26 September 2026. ✅The manufacturer or their Authorised…

Regulatory Alert | EUDAMED becomes mandatory Commission Decision (EU) 2025/2371 confirms the full functionality of the first four EUDAMED modules. As a result, economic operators must comply with mandatory registration requirements. Mandatory modules from 28 May 2026: ✅Market Surveillance ✅Actors: registration of manufacturers, authorised representatives, importers ✅UDI / Devices: device registration (excluding custom-made devices) ✅Notified Bodies &…